The stock of Chart Industries, Inc. (NASDAQ:GTLS) hit a new 52-week high and has $40.90 target or 20.00% above today’s $34.08 share price. The 5 months bullish chart indicates low risk for the $1.13 billion company. The 1-year high was reported on Nov, 17 by Barchart.com. If the $40.90 price target is reached, the company will be worth $226.00M more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock. About 287,073 shares traded hands. Chart Industries, Inc. (NASDAQ:GTLS) has risen 47.38% since April 15, 2016 and is uptrending. It has outperformed by 42.76% the S&P500.
Chart Industries, Inc. (NASDAQ:GTLS) Ratings Coverage
Out of 8 analysts covering Chart Industries (NASDAQ:GTLS), 1 rate it a “Buy”, 0 “Sell”, while 7 “Hold”. This means 13% are positive. Chart Industries has been the topic of 13 analyst reports since July 31, 2015 according to StockzIntelligence Inc. Morgan Stanley maintained Chart Industries, Inc. (NASDAQ:GTLS) on Tuesday, April 19 with “Equal-Weight” rating. Piper Jaffray downgraded Chart Industries, Inc. (NASDAQ:GTLS) on Friday, November 20 to “Neutral” rating. The stock of Chart Industries, Inc. (NASDAQ:GTLS) has “Equal-Weight” rating given on Wednesday, November 4 by Morgan Stanley. Gabelli initiated the stock with “Buy” rating in Tuesday, October 11 report. Craig Hallum downgraded the stock to “Hold” rating in Friday, October 28 report. Lake Street downgraded Chart Industries, Inc. (NASDAQ:GTLS) on Friday, October 30 to “Hold” rating. Lake Street downgraded the shares of GTLS in a report on Friday, October 28 to “Hold” rating. The stock has “Buy” rating given by Lake Street on Friday, April 29. The rating was downgraded by Evercore to “Hold” on Monday, October 31. The company was downgraded on Thursday, August 4 by Evercore.
According to Zacks Investment Research, “CHART INDUSTRIES is a leading independent global manufacturer of highly engineered equipment used in the production, storage and end use of hydrocarbon and industrial gases. Their products are used throughout the liquid gas supply chain for purification, liquefaction, distribution, storage and end use applications, the largest portion of which are energy related.”
More notable recent Chart Industries, Inc. (NASDAQ:GTLS) news were published by: Fool.com which released: “Chart Industries, Inc. Stays on Track As Downturn Plays Out” on October 28, 2016, also Crainscleveland.com with their article: “General counsel of Chart Industries Inc. will leave the company in November” published on October 25, 2016, Crainscleveland.com published: “Chart Industries announces reorganization of its BioMedical Group” on November 07, 2016. More interesting news about Chart Industries, Inc. (NASDAQ:GTLS) were released by: Fool.com and their article: “Chart Industries, Inc. Stock up 10% After Earnings: Here’s Why” published on July 28, 2016 as well as Fool.com‘s news article titled: “Chart Industries, Inc. Stock Down 18% Since Brexit Vote: Here’s What Investors …” with publication date: June 27, 2016.
GTLS Company Profile
Chart Industries, Inc. (Chart), incorporated on June 25, 1992, is a diversified maker of engineered equipment for the industrial gas, energy, and biomedical industries. The Company’s equipment and engineered systems are used for low-temperature and cryogenic applications. It operates through three divisions, including Energy & Chemicals (E&C), Distribution & Storage (D&S), and BioMedical. The Company’s products include vacuum insulated containment vessels, heat exchangers, cold boxes, other cryogenic components and equipment for respiratory therapy. The Company’s E&C and D&S segment’s manufacture products used primarily in energy-related and industrial applications, such as the separation, liquefaction, distribution and storage of hydrocarbon and industrial gases. The Company, through its BioMedical segment, supplies cryogenic and other equipment used in respiratory healthcare and life sciences, including biological research and animal breeding.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.